Haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for prevention of graft-versus-host disease is feasible for patients with acute lymphoblastic leukemia Patients in first complete remission have very good long-term survival Haploidentical donors provide a very suitable alternative to HLA-matched transplantation